|
|
LETTER TO THE EDITOR |
|
Year : 2022 | Volume
: 12
| Issue : 4 | Page : 501 |
|
Branch retinal vein occlusion and COVID-19 vaccination: Correspondence
Won Sriwijitalai1, Viroj Wiwanitkit2
1 Private Academic Consultant, Dimapur, Nagaland, India 2 Department of Community Medicine, Dr. DY Patil University, Pune, Maharashtra, India
Date of Submission | 17-Jul-2022 |
Date of Acceptance | 03-Sep-2022 |
Date of Web Publication | 02-Nov-2022 |
Correspondence Address: Dr. Won Sriwijitalai Private Academic Consultant, Dimapur, 797103 India
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/2211-5056.360248
How to cite this article: Sriwijitalai W, Wiwanitkit V. Branch retinal vein occlusion and COVID-19 vaccination: Correspondence. Taiwan J Ophthalmol 2022;12:501 |
How to cite this URL: Sriwijitalai W, Wiwanitkit V. Branch retinal vein occlusion and COVID-19 vaccination: Correspondence. Taiwan J Ophthalmol [serial online] 2022 [cited 2023 Jan 28];12:501. Available from: https://www.e-tjo.org/text.asp?2022/12/4/501/360248 |
Dear Editor,
We would like to share ideas on the publication “Branch retinal vein occlusion (RVO) post severe acute respiratory syndrome coronavirus 2 vaccination.[1]” Two intriguing RVO cases were described by Tanaka et al.[1] They also observed that both instances suggested a probable link between the SARS-CoV-2 vaccination and the initial beginning of RVO.[1] Clinical medicine emphasizes the clinical influence of the COVID-19 vaccine on other systems notwithstanding the possibility of negative vaccination-related side effects. It may or may not have been a negative vaccine side effect that caused the seizure noted in the recent study. Little is known about the recipient's physical, hematological, ocular, or immunological status before immunization. Because there is no conclusive proof connecting immunization to RVO, making a decision is difficult. Even after receiving vaccinations, a person may already be unwell. The vaccine recipient could also develop a different disease. A co-infection may also appear following the COVID-19 vaccine.[2] For instance, dengue can result in ocular problems if it co-occurs.[3],[4] It is necessary to conduct another prospective analysis of the COVID-19 vaccine's effects on individuals with complete clinical histories. When an incidence has been recorded, a comprehensive laboratory analysis is required to rule out other possibilities.
Financial support and sponsorship
Nil.
Conflicts of interest
The authors declare that there are no conflicts of interests of this paper.
References | |  |
1. | Tanaka H, Nagasato D, Nakakura S, Nagasawa T, Wakuda H, Kurusu A, et al. Branch retinal vein occlusion post severe acute respiratory syndrome coronavirus 2 vaccination. Taiwan J Ophthalmol 2022;12:202-5. [Full text] |
2. | Kebayoon A, Wiwanitkit V. Dengue after COVID-19 vaccination: Possible and might be missed. Clin Appl Thromb Hemost 2021;27:10760296211047229. |
3. | Velaitham P, Vijayasingham N. Central retinal vein occlusion concomitant with dengue fever. Int J Retina Vitreous 2016;2:1. |
4. | Sanjay S, Anilkumar A, Mahendradas P, Kawali A, Priya BV, Shetty BK. Inflammatory branch retinal artery and vein occlusion with panuveitis secondary to dengue fever. Indian J Ophthalmol 2020;68:1958-60.  [ PUBMED] [Full text] |
|